Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis

Overview

Journal J Pers Med

Date 2022 Apr 23

PMID 35455762

Authors

Ulrike Forster-Ruhrmann

Agnieszka J Szczepek

Greta Pierchalla

Joachim W Fluhr

Metin Artuc

Torsten Zuberbier

Claus Bachert

Heidi Olze

Affiliations

Soon will be listed here.

Abstract

Chronic rhinosinusitis (CRS) with (CRSwNP) or without nasal polyps (CRSsNP) is a persistent, heterogeneous inflammatory condition affecting the upper respiratory tract. The present study aimed to improve the characterization of CRS endotypes based on the chemokine and cytokine expression pattern in the CRS tissues. Concentrations of chemokines and cytokines were measured in tissues from nasal biopsies obtained from 66 CRS patients and 25 control subjects using multiplexing or single analyte technologies. Cluster analysis based on the concentration of type-1 (MCP-3/CCL7, MIP-1 α/CCL3), type-2 (IL-5, MCP-3/CCL7, MIP-1 α/CCL3, TARC/CCL17, PARC/CCL18, IP-10/CXCL10, ECP), and type-3 (IL-22) chemokines and cytokines identified six CRS endotypes (clusters). Cluster 1 (type-3) and 2 (type-1) were associated with a low prevalence of nasal polyps, Cluster 3 (type-1, -2, -3) and Cluster 4 (type-2, -3, medium IL-22) with medium, and Cluster 5 (type-2, -3, high Il-22) and Cluster 6 (type-2) with high prevalence of nasal polyps. Asthma was highly prevalent in Cluster-6. Our findings add to the existing knowledge of CRS endotypes and may be useful for the clinical decision-making process. The advancement of biologics therapy for upper respiratory tract disorders rationalizes the personalized diagnostic approach to warrant a successful treatment and monitoring of CRS.

Citing Articles

The causal relationship between autoimmune diseases and rhinosinusitis, and the mediating role of inflammatory proteins: a Mendelian randomization study.

Liang Y, Yin S, Chen X, Li C, Chen Q Exp Biol Med (Maywood). 2024; 249:10196.

PMID: 39104791 PMC: 11299433. DOI: 10.3389/ebm.2024.10196.

Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.

Foerster-Ruhrmann U, Jurkov M, Szczepek A, Bergmann K, Fluhr J, Olze H Biomedicines. 2024; 12(5).

PMID: 38790987 PMC: 11118606. DOI: 10.3390/biomedicines12051025.

Visual and bibliometric analysis of chronic rhinosinusitis and nasal polyps.

Liu Z, Yao Y, Xie H, Zhou A, Fan Y, Liu J J Allergy Clin Immunol Glob. 2024; 3(2):100211.

PMID: 38419685 PMC: 10899047. DOI: 10.1016/j.jacig.2024.100211.

Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice.

Jang J, Yang E, Lee Y, Shin Y, Ye Y, Park H World Allergy Organ J. 2024; 17(3):100879.

PMID: 38380106 PMC: 10877182. DOI: 10.1016/j.waojou.2024.100879.

Temperature influences commensal-pathogen dynamics in a nasal epithelial cell co-culture model.

Huffines J, Boone R, Kiedrowski M mSphere. 2024; 9(1):e0058923.

PMID: 38179905 PMC: 10826359. DOI: 10.1128/msphere.00589-23.

References

Fokkens W, Lund V, Hopkins C, Hellings P, Kern R, Reitsma S . Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020; 58(2):82-111. DOI: 10.4193/Rhin20.601. View

Bachert C, Han J, Desrosiers M, Hellings P, Amin N, Lee S . Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019; 394(10209):1638-1650. DOI: 10.1016/S0140-6736(19)31881-1. View

Delemarre T, Bochner B, Simon H, Bachert C . Rethinking neutrophils and eosinophils in chronic rhinosinusitis. J Allergy Clin Immunol. 2021; 148(2):327-335. PMC: 8355033. DOI: 10.1016/j.jaci.2021.03.024. View

Maurer M, von Stebut E . Macrophage inflammatory protein-1. Int J Biochem Cell Biol. 2004; 36(10):1882-6. DOI: 10.1016/j.biocel.2003.10.019. View

Kapitany A, Beke G, Nagy G, Doan-Xuan Q, Bacso Z, Gaspar K . CD1c+ Blood Dendritic Cells in Atopic Dermatitis are Premature and Can Produce Disease-specific Chemokines. Acta Derm Venereol. 2016; 97(3):325-331. DOI: 10.2340/00015555-2540. View

Vaitkus J, Vitkauskiene A, Simuntis R, Vaitkus Z, Siupsinskiene N, Vaitkus S . Chronic Rhinosinusitis with Nasal Polyps: Age and Disease Severity Differences in the Levels of Inflammatory Markers. Medicina (Kaunas). 2021; 57(3). PMC: 8002897. DOI: 10.3390/medicina57030282. View

Kim D, Eun K, Roh E, Shin S, Kim D . Chronic Rhinosinusitis without Nasal Polyps in Asian Patients Shows Mixed Inflammatory Patterns and Neutrophil-Related Disease Severity. Mediators Inflamm. 2019; 2019:7138643. PMC: 6350559. DOI: 10.1155/2019/7138643. View

Hastan D, Fokkens W, Bachert C, Newson R, Bislimovska J, Bockelbrink A . Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011; 66(9):1216-23. DOI: 10.1111/j.1398-9995.2011.02646.x. View

Proost P, Van Leuven P, Wuyts A, Ebberink R, Opdenakker G, Van Damme J . Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines. Cytokine. 1995; 7(2):97-104. DOI: 10.1006/cyto.1995.1013. View

10.

Bonecchi R, Bianchi G, Bordignon P, DAmbrosio D, Lang R, Borsatti A . Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187(1):129-34. PMC: 2199181. DOI: 10.1084/jem.187.1.129. View

11.

Rot A, Krieger M, Brunner T, Bischoff S, Schall T, Dahinden C . RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med. 1992; 176(6):1489-95. PMC: 2119467. DOI: 10.1084/jem.176.6.1489. View

12.

Gevaert P, Omachi T, Corren J, Mullol J, Han J, Lee S . Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol. 2020; 146(3):595-605. DOI: 10.1016/j.jaci.2020.05.032. View

13.

Takahashi K, Hirose K, Kawashima S, Niwa Y, Wakashin H, Iwata A . IL-22 attenuates IL-25 production by lung epithelial cells and inhibits antigen-induced eosinophilic airway inflammation. J Allergy Clin Immunol. 2011; 128(5):1067-76.e1-6. DOI: 10.1016/j.jaci.2011.06.018. View

14.

Elsner J, Escher S, Forssmann U . Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy. 2004; 59(12):1243-58. DOI: 10.1111/j.1398-9995.2004.00710.x. View

15.

Kim D, Eun K, Kim M, Cho D, Han S, Han S . Comparison Between Signature Cytokines of Nasal Tissues in Subtypes of Chronic Rhinosinusitis. Allergy Asthma Immunol Res. 2019; 11(2):201-211. PMC: 6340796. DOI: 10.4168/aair.2019.11.2.201. View

16.

Sallusto F, Lenig D, Mackay C, Lanzavecchia A . Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998; 187(6):875-83. PMC: 2212187. DOI: 10.1084/jem.187.6.875. View

17.

Bullone M, Carriero V, Bertolini F, Folino A, Mannelli A, Di Stefano A . Elevated serum IgE, oral corticosteroid dependence and IL-17/22 expression in highly neutrophilic asthma. Eur Respir J. 2019; 54(5). DOI: 10.1183/13993003.00068-2019. View

18.

Walz A, Schmutz P, Mueller C, Schnyder-Candrian S . Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol. 1997; 62(5):604-11. DOI: 10.1002/jlb.62.5.604. View

19.

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo J, Eberl G . Innate Lymphoid Cells: 10 Years On. Cell. 2018; 174(5):1054-1066. DOI: 10.1016/j.cell.2018.07.017. View

20.

Tomassen P, Vandeplas G, Van Zele T, Cardell L, Arebro J, Olze H . Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016; 137(5):1449-1456.e4. DOI: 10.1016/j.jaci.2015.12.1324. View